CN1163252C - Tianjian capsule and its preparing process - Google Patents
Tianjian capsule and its preparing process Download PDFInfo
- Publication number
- CN1163252C CN1163252C CNB001178482A CN00117848A CN1163252C CN 1163252 C CN1163252 C CN 1163252C CN B001178482 A CNB001178482 A CN B001178482A CN 00117848 A CN00117848 A CN 00117848A CN 1163252 C CN1163252 C CN 1163252C
- Authority
- CN
- China
- Prior art keywords
- medicine
- ganoderma
- capsule
- endothelium corneum
- gigeriae galli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese patent medicine for treating tumors, particularly to a tianjian capsule, an ancillary medicine for preventing and treating tumors. The tianjian capsule is prepared from traditional Chinese medicine raw materials of the following proportion by weight: 35 to 50 of notoginseng, 15 to 25 of ganoderma, 15 to 25 of largehead atractylodes rhizome, 5 to 15 of radices paeoniae alba and 5 to 15 of gizzard lining. The tianjian capsule is a traditional Chinese medicine preparation having the functions of inhibiting tumor development, maintaining the whole function of human bodies, reducing the side effect of traditional Chinese medicines in the process of chemical treatment and improving curative effect. The capsule has the advantage of convenient administration without toxic or side effect. The curative rate of one treatment course reaches 95%.
Description
Technical field
The invention belongs to a kind of Chinese patent medicine for the treatment of tumor, particularly relate to a kind of medicine and preparation method thereof of ancillary drug adjuvant therapy of tumors of antineoplaston.
Background technology
Tumor disease is a kind of pertinacious disease, add up according to health organization, the sickness rate of various tumors and cancer is the trend that rises year by year, human beings'health in its serious threat, because modern medicine does not still have a kind of specially good effect good medicine for the treatment of cancer and tumor, present Therapeutic Method is to early, mid-term, cancer and tumor patient were carried out operative treatment, the bonded Therapeutic Method of chemotherapy and Western medicine, doctor trained in Western medicine anticarcinogen commonly used has cyclophosphamide, compound recipe is urinated the pyridine of vomiting of quarrelling, the amino pyridine sheet etc. that drips, these side effects of pharmaceutical drugs are big, DeGrain, kill cancer cell not only in chemotherapy process, and cause the normal cell sudden change, bring out other diseases, make the patient can not accept normal therapeutic, therefore, developing the auxiliary Chinese medicine preparation of the little antineoplaston of a kind of side effect, is numerous doctors and patient's common expectation.
Summary of the invention
The medicine that the purpose of this invention is to provide a kind of adjuvant therapy of tumors that can use as anticancer adjuvant.
Technical solution of the present invention is to the pathogeny of generation, development and the transfer of tumor and cancer and Therapeutic Principle's understanding according to motherland's traditional medicine, study in conjunction with modern pharmacology, from motherland's traditional Chinese medical science treasure-house, filter out and have no side effect, can suppress tumor development, safeguard the allomeric function of body, alleviate the side effect reflection of chemotherapeutics, to improve the Chinese herbal medicine of curative effect, press the tcm theory prescription, develop medicine of adjuvant therapy of tumors of the present invention and preparation method thereof.
The medicine of adjuvant therapy of tumors of the present invention is made by following raw materials in weight portion
Radix Notoginseng 35-50, Ganoderma 15-25, Rhizoma Atractylodis Macrocephalae 15-25, Radix Paeoniae Alba 5-15, Endothelium Corneum Gigeriae Galli 5-15;
Preferred weight part ratio range of each component of capsule of the present invention is:
Radix Notoginseng 42-48, Ganoderma 17-22, Rhizoma Atractylodis Macrocephalae 17-22, Radix Paeoniae Alba 7-10, Endothelium Corneum Gigeriae Galli 7-10;
The capsular optimum weight part of preparation the present invention proportioning is:
Radix Notoginseng 45, Ganoderma 19, the Rhizoma Atractylodis Macrocephalae 20, the Radix Paeoniae Alba 8, Endothelium Corneum Gigeriae Galli 8;
Radix Notoginseng among the present invention is the root of Araliaceae Radix Notoginseng Panax notoginseng (Burk) F.H.Chen, cleans, grinds into fine powder after the drying.Removing stasis to stop bleeding is arranged, the analgesic therapy of invigorating blood circulation, adrenal cortex reinforcing function, regulate carbohydrate metabolism, protect the liver, defying age and antitumor action.
Ganoderma among the present invention is the Herb after clean the drying of Polyporaceae plant Ganoderma lucidum (Leyss. Ex Fr.) Karst. Ganoderma lucidum (Leyss.exfr.) Karst.The effect of tranquilizing by nourishing the heart, relieving cough and asthma, benefiting qi and nourishing blood is arranged, also can be used for leukopenia that coronary heart disease, hypertension, hyperlipidemia, hepatitis, tracheitis and multiple reason cause etc.The fine powder that the present invention obtains after pulverizing with Ganoderma.
The Rhizoma Atractylodis Macrocephalae among the present invention is a feverfew Rhizoma Atractylodis Macrocephalae Atractylodes macrocephala Koidz. rhizome.Grind into flour after clean the drying.Have air making-up and spleen enlivening, dampness diuretic, hidroschesis, spleen invigorating loosening bowel to relieve constipation, the liver protecting, blood sugar lowering and anticoagulant effect.Fine powder after the present invention pulverizes with the Rhizoma Atractylodis Macrocephalae.
The Radix Paeoniae Alba among the present invention is the dry root of cohosh Radix Paeoniae Paeonia lactiflora Poll..Have effects such as the yin fluid astringing of enriching blood, easing the affected liver to relieve pain, pancake liver-yang.Fine powder after the present invention pulverizes with the Radix Paeoniae Alba.
Endothelium Corneum Gigeriae Galli among the present invention is the cutin inwall of the dry ballast of the female animal chicken Gallus gallus domesticus Brissos. of section, has strengthening the spleen to promote digestion, controlling nocturnal emission with astringent drugs only something lost, treating stranguria calculi dissolving function.Fine powder after the present invention pulverizes with Endothelium Corneum Gigeriae Galli.
With above-mentioned each component preparation cost invention medicine production method be:
1, get Radix Notoginseng and Endothelium Corneum Gigeriae Galli, be dried and crushed into fine powder, standby;
2, Ganoderma is extracted three times with 70% alcohol heating reflux, each three hours, merges three extracting solution, recovery ethanol, standby;
3, the Rhizoma Atractylodis Macrocephalae is heated up in a steamer extraction volatile oil with water vapour, volatile oil is with the absorption of 10 times of amount beta-schardinger dextrin-s, and is standby, and the medicinal liquid after distillation device is in addition preserved;
4, the Ganoderma medicinal residues behind the Radix Paeoniae Alba and above-mentioned 70% ethanol extraction are decocted with water secondary, each one hour, medicinal liquid after getting the medicinal liquid after supernatant and the above-mentioned distillation and reclaiming ethanol merges, be concentrated in right amount, add Radix Notoginseng and Endothelium Corneum Gigeriae Galli fine powder, mix thoroughly, granulate, dry, the volatile oil that adds beta-schardinger dextrin-absorption, mixing, incapsulate, make 0.45 gram/grain, ± 10% finished product.
The dosage that medicine of the present invention is used for the treatment of is adult every day three times, and each three, be one month a course of treatment.The present invention has the raising phagocytic function, improves effects such as T lymphocyte transformation function, raising NK cell killing function, and the present invention is a pure Chinese medicinal preparation, have no side effect, and taking convenience, the cure rate of a course of treatment reaches 95%.
The medicine of adjuvant therapy of tumors of the present invention is carrying out clinical research, and the medicine name that uses during the clinical research is " Tianjian capsule ".
Claims (4)
1, a kind of medicine of adjuvant therapy of tumors is characterized in that it is made by following raw materials in weight portion:
Radix Notoginseng 35-50, Ganoderma 15-25, Rhizoma Atractylodis Macrocephalae 15-25, Radix Paeoniae Alba 5-15, Endothelium Corneum Gigeriae Galli 5-15.
2, the medicine of adjuvant therapy of tumors according to claim 1 is characterized in that the weight portion ratio range of each component is: Radix Notoginseng 42-48, Ganoderma 17-22, Rhizoma Atractylodis Macrocephalae 17-22, Radix Paeoniae Alba 7-10, Endothelium Corneum Gigeriae Galli 7-10.
3, the medicine of adjuvant therapy of tumors according to claim 1 is characterized in that the weight proportion of described each raw material is: Radix Notoginseng 45; Ganoderma 19; The Rhizoma Atractylodis Macrocephalae 20; The Radix Paeoniae Alba 8; Endothelium Corneum Gigeriae Galli 8.
4, the method for the medicine of the described adjuvant therapy of tumors of preparation claim 1 is characterized in that may further comprise the steps:
(1) get Radix Notoginseng and Endothelium Corneum Gigeriae Galli, be dried and crushed into fine powder, standby;
(2) Ganoderma is extracted three times with 70% alcohol heating reflux, each three hours, merges three extracting solution, recovery ethanol, standby;
(3) Rhizoma Atractylodis Macrocephalae is heated up in a steamer extraction volatile oil with water vapour, volatile oil is with the absorption of 10 times of amount beta-schardinger dextrin-s, and is standby, and the medicinal liquid after distillation device is in addition preserved;
(4) the Ganoderma medicinal residues behind the Radix Paeoniae Alba and above-mentioned 70% ethanol extraction are decocted with water secondary, each one hour, medicinal liquid after getting the medicinal liquid after supernatant and the above-mentioned distillation and reclaiming ethanol merges, be concentrated in right amount, add Radix Notoginseng and Endothelium Corneum Gigeriae Galli fine powder, mix thoroughly, granulate, dry, the volatile oil that adds beta-schardinger dextrin-absorption, mixing, incapsulate, make 0.45 gram/grain, ± 10% finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001178482A CN1163252C (en) | 2000-05-25 | 2000-05-25 | Tianjian capsule and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001178482A CN1163252C (en) | 2000-05-25 | 2000-05-25 | Tianjian capsule and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1325710A CN1325710A (en) | 2001-12-12 |
| CN1163252C true CN1163252C (en) | 2004-08-25 |
Family
ID=4587086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001178482A Expired - Fee Related CN1163252C (en) | 2000-05-25 | 2000-05-25 | Tianjian capsule and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1163252C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010133009A1 (en) * | 2009-05-18 | 2010-11-25 | 南京中科集团股份有限公司 | A anti-tumor chinese drugs preparation comprising lucidum spores oil and preparation method thereof |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943945A (en) * | 2016-06-18 | 2016-09-21 | 冯原 | Traditional Chinese medicine composition for treating lung cancer, dripping pills and preparation method of dripping pills |
| CN116474061A (en) * | 2022-01-13 | 2023-07-25 | 罗登 | Medicine for treating side effects of tumor radiotherapy and chemotherapy and preparation method thereof |
-
2000
- 2000-05-25 CN CNB001178482A patent/CN1163252C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010133009A1 (en) * | 2009-05-18 | 2010-11-25 | 南京中科集团股份有限公司 | A anti-tumor chinese drugs preparation comprising lucidum spores oil and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1325710A (en) | 2001-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1263503C (en) | 'Changyuan' capsule and preparing techniue | |
| CN1163252C (en) | Tianjian capsule and its preparing process | |
| CN101518607B (en) | Traditional Chinese medicine for treating carcinoma of kidney | |
| CN1185000C (en) | Medicine for treating cyst | |
| CN1144595C (en) | Anticancer capsule | |
| CN1232281C (en) | Chinese medicine for treating osteoporosis and its preparation method | |
| CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
| CN1079252C (en) | Compound graceful jassamine preparation | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN101194959B (en) | Capsule for treating headache and method for preparing the same | |
| CN1270768C (en) | Medicine for treating cold disease | |
| CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
| CN1116050C (en) | Medicine bolus for dredging meridian passage, nourishing blood and removing toxic material | |
| CN1151813C (en) | Traditional Chinese medicine composition for curing insomnia | |
| CN1225269C (en) | Medicine for treating prospoalgia | |
| CN101194963B (en) | Process for preparing medicine for treating headache | |
| CN1099886C (en) | Biaining as one medicine for nasopharyngeal cancer | |
| CN101700323B (en) | Pharmaceutical composition for preventing and treating liver cancer | |
| CN101085185A (en) | Beverage containing white peony root and gardenia | |
| CN100339093C (en) | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN1440802A (en) | Gastritis treating Chinese medicine | |
| CN1091381C (en) | Medicine composition for curing angiocardiopathy and cerebrovascular disease and its preparation method | |
| CN1102405C (en) | Chinese medicine for treating acyesis | |
| CN1068217C (en) | Traditional Chinese medicine for treating skin disease and veneral disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |